Progetti di ricerca sul cancro presso il Weizmann Institute of Science
In questa sezione sono riportati tutti i progetti di ricerca sul cancro in corso al Weizmann Institute of Science, associati alle borse di studio che assegna il Sergio Lombroso Program.
Il vincitore della borsa di studio si unirà ad uno dei team di ricerca già al lavoro presso il Weizmann Institute of Science.
Using special flow chambers that simulate blood flow and intravital microscopy in genetically manipulated mice, Prof. Alon and his team are investigating how both endothelial and perivascular trafficking molecules promote...
Prof. Benjamin Geiger, Department of Molecular Cell Biology email@example.com Prof. Benjamin Geiger’s research focuses on the molecular mechanisms that control cellular adhesion and migration. In
Prof. Eytan Domany, Department of Physics of Complex Systems firstname.lastname@example.org The main research activity of Prof. Domany’s group is trying to mine data from large-scale
Dr. Ayelet Erez, Department of Biological Regulation email@example.com A physician-scientist, Dr. Ayelet Erez is a geneticist and medical doctor who treat families with genetic cancer
Dr. Ido Amit, Department of Immunology firstname.lastname@example.org Prof. Ido Amit pioneered single cell genomic technologies and their application to the characterization of the immune system. Answering
Prof. Uri Alon, Department of Molecular Cell Biology email@example.com When a number of chemotherapy drugs are used for treating cancer, they must work well together,
Prof. Ronen Alon, Department of Immunology firstname.lastname@example.org Examining how immune cells and metastatic cancer cells migrate into and out of the blood vessels in which
Prof. Adi Kimchi, Department of Molecular Genetics email@example.com Programmed cell death is the principal mechanism by which cells are physically eliminated in our body. Cancer
Prof. Valery Krizhanovsky, Department of Molecular Cell Biology firstname.lastname@example.org Cellular senescence, an age-associated and irreversible form of cell cycle arrest which limits cells’ proliferative potential,
Prof. Tsvee Lapidot, Department of Immunology email@example.com Stem cell transplantion is a treatment for some cancers, including leukemias, as well as for immune deficiencies linked
Prof. Sima Lev, Department of Molecular Cell Biology firstname.lastname@example.org The research of Prof. Sima Lev focuses on TBNC, or “triple negative” breast cancer – a
Prof. Michal Neeman, Department of Biological Regulation email@example.com Prof. Michal Neeman’s research focuses on mechanisms that regulate angiogenesis—the development of new blood vessels—particularly in ovarian
Prof. Moshe Oren, Department of Molecular Cell Biology firstname.lastname@example.org Prof. Oren is studying a key player in molecular cancer control—the tumor suppressor gene called p53.
Prof. Varda Rotter, Department of Molecular Cell Biology email@example.com Prof. Varda Rotter is among the pioneers who discovered the p53 protein, and provided original insights
Prof. Yinon Rudich, Department of Earth and Planetary Sciences firstname.lastname@example.org Prof. Yinon Rudich is an expert on aerosols—the airborne dust that has a significant impact
Prof. Yardena Samuels email@example.com The research of Prof. Yardena Samuels focuses on cancer genomics and immuno-genomics in melanoma. In her postdoctoral work, Prof. Samuels discovered a
Prof. Avigdor Scherz, Department of Plant and Environmental Sciences firstname.lastname@example.org Prof. Avigdor Scherz is a plant scientist who has parleyed his knowledge of photosynthetic materials
Dr. Ruth Scherz-Shouval, Department of Biomolecular Sciences email@example.com Dr. Scherz-Shouval examines how cancer cells recruit and subvert normal cells to create an environment that promotes
Prof. Idit Shachar, Department of Immunology Prof. Idit Shachar’s research focuses on factors that affect mature peripheral lymphocytes–a subtype of the white blood cells that
Dr. Ziv Shulman, Department of Immunology firstname.lastname@example.org Dr. Ziv Shulman studies the cellular and molecular processes that lead to the generation of protective antibodies in
Dr. Ravid Straussman, Department of Molecular Cell Biology email@example.com The Straussman lab studies mechanisms of resistance to anti-cancer therapies. After demonstrating that cells of the tumor
Dr. Amos Tanay, Department of Computer Science and Applied Mathematics; Department of Biological Regulation firstname.lastname@example.org The field of epigenetics deals with molecular mechanisms that allow
Prof. Yosef Yarden, Department of Biological Regulation email@example.com Much of Prof. Yosef Yarden’s research is centered on EGFR, a family of growth factor receptors that play a
The Alon lab focuses on understanding the protein circuits that perform computations within the cell.
Dr. Amit studies the genomic code enabling immune cells to differentiate into specific subtypes and devise a specific response to invading pathogens.
Prof. Kimchi’s lab is studying programmed cell death by proceeding from single-gene studies to a global network analysis.
Dr. Krizhanovsky is working to uncover the mechanisms of interaction of the senescent cells with their microenvironment, in order to understand the role of cellular senescence in tissue damage, cancer, and aging.
Prof. Lapidot and his team are primarily focused on the activities and regulation of blood-forming (hematopoietic) stem cells.
The long- term goal of Prof. Lev’s studies is to define the signaling pathways and the intracellular signaling components that contribute to the development and progression of breast cancer.
Prof. Livneh’s laboratory investigates the molecular mechanisms of DNA repair and mutagenesis and their biological role under normal and pathological conditions, primarily cancer.
Prof. Neeman’s research centers on elucidating the mechanisms that regulate angiogenesis, using magnetic resonance and optical imaging.
The main goals of Prof. Oren are to elucidate the processes that underlie the ability of p53 to act as a tumor suppressor and the mechanistic links between regulation of gene expression and cancer.
Research in Prof. Rotter’s lab is focused on revealing the mechanism by which wild-type p53 acts in normal cells and the way in which mutant p53 contributes to cancer development.
Prof. Sagi and her lab focus on the cell microenvironment which includes the extracellular matrix.
Prof. Samuel’s group aims to discover recurrent tumor-specific mutations in melanoma using high- throughput, whole-exome, and whole-genome sequencing approaches.
Dr. Shouval and her group aim to elucidate the mechanisms by which tumors reprogram their local environments.
Prof. Segal’s group develops computational models aimed at understanding how molecular components interact to carry out complex biological functions.
Prof. Seger’s current studies focus on the mechanism by which the linear signaling cascades induce many distinct, and even opposing, physiological and pathological processes.
The Shachar lab follows Lymphoid homeostasis events during health and disease, focusing on three key areas...
The Straussman group studies different mechanisms which render cancer cells resistant to chemotherapy.
Dr. Amos Tanay’s group is studying the physical interfaces that associate genomic information with mechanisms that interpret it in the nucleus.
Dr. Shlush and his team study leukemia evolution from diagnosis to relapse. They can detect from the blood of AML patients the non-leukemic subpopulations that were ancestral to the leukemic cells and...
The main interest of the Yaniv lab is to understand the mechanisms controlling the formation of blood and lymphatic vessels during embryonic development...
Prof. Yarden addresses the effect of the ErbB family on the mobility of tumor cells and on their ability to cross tissue barriers.
A physician-scientist, Dr. Erez is working to decipher the dynamics of cellular metabolism at different disease states.